Small Molecules

How the Drugs for Neglected Diseases Initiative and the Malaysian government partnered to tackle hep C with an affordable, effective cure.

Has pharma fully acknowledged the power of rapid-dissolve tablet technologies?

Precious metals-bearing catalysts are essential in some pharma processes – but, once they’re spent, they still hold value.

Eli Lilly’s Loxo Oncology has signed a deal with Yi Liu’s Kumquat Biosciences, targeting novel small molecules for immuno-oncology.

Can AI facilitate a grand comeback for medicines sourced from Mother Nature?

Advanz Pharma is fined for substantially hiking the price of a generic drug.

How do we reduce the presence of pharmaceuticals in water?

Nominations are now open for The Medicine Maker 2021 Innovation Awards.

How is the OTC industry rising to pharma's biggest challenges?

Experts from Colorcon explain how the company’s investments in facilities and new technologies are helping the pharma sector reach its goals.